SCHEMBL5696704

SCHEMBL5696704

Cc1cccc(COc2ccc(Nc3ncnc4cccc(OCC5CCCN5C(=O)CN(C)C)c34)cc2Cl)n1

nearest known ligand 0.71

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 18/20 0.71
EGFR P00533 10/20 0.71
KCNH2 Q12809 7/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384884 1.00 ERBB2 (0.71) ERBB2EGFRKCNH2
SCHEMBL4385166 0.93 ERBB2 (0.82) ERBB2EGFRKCNH2
SCHEMBL5481649 0.93 ERBB2 (0.82) ERBB2EGFRKCNH2
SCHEMBL4384983 0.91 ERBB2 (0.85) ERBB2EGFRKCNH2
SCHEMBL5697194 0.91 ERBB2 (0.85) ERBB2EGFRKCNH2
SCHEMBL4387008 0.91 ERBB2 (0.85) ERBB2EGFRKCNH2
SCHEMBL4389085 0.91 ERBB2 (0.79) ERBB2EGFRKCNH2
SCHEMBL5696688 0.90 ERBB2 (0.68) ERBB2EGFRKCNH2
SCHEMBL4385165 0.90 ERBB2 (0.68) ERBB2EGFRKCNH2
SCHEMBL4384872 0.89 ERBB2 (0.81) ERBB2EGFRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664029-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2006-06-07 EP disclosed
WO-2005026152-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2005-03-24 WO disclosed